Total Mesorectal Excision with or without Lateral Pelvic Lymph Node Dissection in Rectal Cancer
International Journal of Surgical Oncology · 2023
DOI: 10.1155/2023/6653624 ↗Kurz gefasst
Fachartikel in der Zeitschrift International Journal of Surgical Oncology, 2023. Verfasst von Mohamed Yehia Elbarmelgi und 4 weiteren Autor:innen. Beteiligte Einrichtung: General and Colorectal Surgery, Cairo University, Giza, Egypt. Hauptthemen laut MEDLINE: Blood Loss, Surgical, Rectal Neoplasms. Die Arbeit nennt 26 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Cairo University.
Abstract (Originalsprache)
Backgrounds and Aims. The benefit of lateral pelvic lymph node dissection (LPLD) for rectal cancer remains controversial. The aim of this study was to assess the incidence of local recurrence between patients who underwent total mesorectal excision (TME) with and without LPLD in rectal cancer. Patients and Methods. The study was conducted on 92 patients presenting with extraperitoneal rectal cancer (T3 and T4) in the colorectal department at our hospital. Patients were divided into two groups: Group A was subjected to total mesorectal excision (TME) after neoadjuvant chemoradiation and Group B was subjected to TME with LPLD with autonomic nerve preservation. Patients were followed up for the incidence of local recurrence, distant recurrence, and urinary and sexual dysfunctions. Results. Incidence of local recurrence was slightly higher in Group A (8.7%) than in Group B (4.3%) but was not statistically significant. There was no statistical significance between both groups regarding distant metastasis (8.7% in Group A and 13% in Group B). Urinary and sexual dysfunctions were higher in Group B (26.1%) compared to those in Group A (21.7%) but were not statistically significant. The incidence of lateral pelvic lymph node metastasis was 30.4%. Also, intraoperative blood loss was higher and operative time was longer in Group B which was statistically significant ( P value
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Autor:innen und Institutionen
- General and Colorectal Surgery, Cairo University, Giza, Egypt.
- General Surgery, Cairo University, Giza, Egypt.
ORCID-Profile: Mohamed Yehia Elbarmelgi
Förderung
- Cairo University
Zitieren
APA
Elbarmelgi, M. Y., Abdelaal, A. M., Refaie, O., Tamer, M., & Shafik, A. A. (2023). Total Mesorectal Excision with or without Lateral Pelvic Lymph Node Dissection in Rectal Cancer. International Journal of Surgical Oncology. https://doi.org/10.1155/2023/6653624
Vancouver
Elbarmelgi MY, Abdelaal AM, Refaie O, Tamer M, Shafik AA. Total Mesorectal Excision with or without Lateral Pelvic Lymph Node Dissection in Rectal Cancer. International Journal of Surgical Oncology. 2023. doi:10.1155/2023/6653624
BibTeX
@article{Elbarmelgi2023,
author = {Elbarmelgi, Mohamed Yehia and Abdelaal, Ahmed Mohamed and Refaie, Osama and Tamer, Mohamed and Shafik, Ali Ahmed},
title = {Total Mesorectal Excision with or without Lateral Pelvic Lymph Node Dissection in Rectal Cancer},
journal = {International Journal of Surgical Oncology},
year = {2023},
doi = {10.1155/2023/6653624}
}
EUVIMED